ViewpointLessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension
Section snippets
Cardiac and Vascular Effects of Aldosterone
Aldosterone is usually thought of in connection with its renal tubular effects, with retention of salt and water raising blood pressure, and excretion of potassium and magnesium affecting heart rhythm18 and the metabolic syndrome.19 However, there is strong evidence that aldosterone also aggravates heart failure by effects on myocardial extracellular matrix,20 and aggravates atherosclerosis, via inflammation and other effects on the artery wall.21, 22, 23, 24, 25 As reviewed recently by
Physiologically Individualized Therapy Based on Plasma Renin and Aldosterone
The management of resistant hypertension can be substantially improved by measuring plasma renin and aldosterone, to guide individualized therapy.37 The algorithm is described in Table 1.
A version of that approach was shown in a randomized controlled trial by Egan et al., to improve blood pressure control in a hypertension clinic in Charleston, South Carolina.38 The algorithm described in Table 1 is more specific because there are two main groups of low-renin hypertensive patients—those with
Conclusions
Measuring plasma aldosterone in addition to plasma renin adds importantly to management of resistant hypertension in two ways: (1) it permits identification of low-renin patients who have low levels of aldosterone because of Liddle's variants, who are specifically treated with amiloride; and (2) it identifies patients with high levels of plasma aldosterone, who would benefit from aldosterone antagonism, not only to achieve control of their hypertension, but to minimize the direct adverse
Disclosures
The author has received grants and/or research support from HSF, NIH, CIHR, and Merck; honoraria for lectures from Merck, Boehringer-Ingelheim, and Bayer; consulting fees from Novartis and Boehringer-Ingelheim; and has an interest in www.vascularis.com.
The author's group is testing the possibility that eplerenone may slow progression of carotid atherosclerosis in a study funded by HSF Ontario; this is supported in part by donation of study drug and placebo by Pfizer Inc. An application has been
References (46)
- et al.
Rapid vascular effects of steroids–a question of balance?
Can J Cardiol
(2010) - et al.
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study
J Am Coll Cardiol
(2010) - et al.
Resistant hypertension and aldosterone: an update
Can J Cardiol
(2012) - et al.
Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
J Am Soc Hypertens
(2010) - et al.
Whites excrete a water load more rapidly than blacks
Hypertension
(2009) - et al.
Differences in hypertension between blacks and whites: an overview
Cardiovasc J Afr
(2007) - et al.
Hypertension in sub-Saharan African populations
Circulation
(2005) Physiologic tailoring of treatment in resistant hypertension
Current Cardiology Rev
(2010)- et al.
Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study
Stroke
(2006) - et al.
Heart disease and stroke statistics–2009 updateA report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation
(2009)
Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke Study
Circulation
The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension
Cardiovasc J Afr
The prevalence and relationship to hypertension of the R563Q mutation of the epithelial sodium channel in Southern Africa
Cardiovasc J Afr
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension
J Hypertens
Amiloride, a specific drug for hypertension in black people with T594M variant?
Hypertension
High prevalence of Liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana
J Clin Hypertens (Greenwich)
Salt, slavery and survival–hypertension in the African diaspora
Epidemiology
Update in primary aldosteronism
J Clin Endocrinol Metab
Resistant hypertension: diagnosis, evaluation, and treatmentA scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
Hypertension
The prevalence of adrenal cortical hyperplasia at autopsy and its association with hypertension
Ann Intern Med
Association of adrenal steroids with hypertension and the metabolic syndrome in blacks
Hypertension
Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program
Hypertension
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study
J Hypertens
Cited by (33)
Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology
2019, Current Opinion in Endocrine and Metabolic ResearchHypertension in black patients
2018, JMV-Journal de Medecine VasculaireRational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
2017, Canadian Journal of CardiologyCitation Excerpt :Simply adding a diuretic might have been all that was required. The algorithm described in Table 2 is used as follows: low renin/high aldosterone patients (a primary aldosteronism phenotype) are best treated with aldosterone antagonists; low renin/low aldosterone patients (a Liddle phenotype) are best treated with amiloride,7 and high renin/high aldosterone patients are best treated with angiotensin receptor blockers.7 For primary aldosteronism surgery is rarely indicated, because most primary aldosteronism (particularly in black individuals7) is probably from bilateral hyperplasia.
Specifities of hypertension management in sub-Saharan type 2 diabetic patient
2017, Medecine des Maladies MetaboliquesApparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack
2015, American Journal of MedicineCitation Excerpt :That persons of African ancestry are more likely to have apparent treatment-resistant hypertension and specific associated pathophysiology of hypertension (ie, low-renin hypertension, etc) has been suggested as a major contributor to the black–white stroke disparity.37 Therefore, especially in blacks, it is recommended that physicians take an individualized approach to assess and manage BP levels, including additional diagnostic evaluations including measurement of plasma renin, aldosterone-changing medications, and incorporating advice related to lifestyle changes.19,38 The supplemental analysis restricted to those taking diuretic medication showed a substantial mediation of the risk in blacks, suggesting that treatment with diuretics may be a key to this individualized approach.
Blood pressure control in Canada: The view from a stroke prevention clinic
2015, Canadian Journal of Cardiology
See page 255 for disclosure information.